Sort
326,823 grants matching “clinical trial”
Antigen-specific T-cell activation, application to vaccines for Cancer and AIDS
$2,029,401Jay A Berzofsky · Clinical Sciences · Z01 · FY2007 · CA
Developmental Therapeutics Program
$2,029,064James V Degregori · University Of Colorado Denver · P30 · FY2025 · CA
THE ALLIANCE NCTN BIOREPOSITORY AND BIOSPECIMEN RESOURCE
$2,029,001Mark A Watson · Washington University · U24 · FY2017 · CA
Immunopathogenesis of Acute HIV-1 Infection
$2,028,889Elizabeth Connick · University Of Colorado Denver · P01 · FY2006 · AI
The Effectiveness of Family-based Weight Loss Treatment Implemented in Primary Care - CCC - Lead Application
$2,028,875Leonard H Epstein · State University Of New York At Buffalo · U01 · FY2017 · HL
Head and Neck Cancer SPORE at the University of Wisconsin
$2,028,647Paul M Harari · University Of Wisconsin-Madison · P50 · FY2022 · CA
ADULT AIDS CLINICAL TRIALS UNIT
$2,028,458Indiana Univ-Purdue Univ At Indianapolis · U01 · FY2003 · AI
Strategies for Cancer Immunotherapy Development: Preclinical Studies
$2,028,388Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Study of Oxytocin in Autism to Improve Reciprocal Social Behaviors (SOARS-B)
$2,028,182Linmarie Sikich · Duke University · U01 · FY2015 · HD
HIV-1 Vaccines Designed to Induce Mucosal Immunity
$2,028,178University Of California Davis · U19 · FY2004 · AI
Immunologic and Neurodevelopmental Consequences of Neonatal Anemia and Thrombocytopenia and their Treatments
$2,028,003Martha C Sola-Visner · Boston Children'S Hospital · P01 · FY2019 · HL
Northeast Node of the National Drug Abuse Clinical Trials Network
$2,027,951Lisa A Marsch · Dartmouth College · UG1 · FY2022 · DA
Dietary Restriction, GH/IGF-1 & Mechanisms of Cellular Protection and Regeneration
$2,027,936Valter D. Longo · University Of Southern California · P01 · FY2019 · AG
Trial to Assess Chelation Therapy 2- TACT2 CCC
$2,027,925Gervasio A Lamas · Mount Sinai Medical Center (Miami Beach) · UH3 · FY2017 · AT
Count Me In: Partnering with patients to define the clinical and genomic landscape of rare aggressive sarcomas in children and adults
$2,027,859Katherine A Janeway · Broad Institute, Inc. · U2C · FY2022 · CA
Mechanisms of naturally-acquired immunity to malaria
$2,027,646Peter Crompton · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Mental Health Research Network III
$2,027,584Gregory E Simon · Kaiser Foundation Research Institute · U19 · FY2021 · MH
Human T-Cell Responses to Tumor Antigens
$2,027,509Jeffrey Schlom · Basic Sciences · Z01 · FY2007 · CA
Immunologic and Neurodevelopmental Consequences of Neonatal Anemia and Thrombocytopenia and their Treatments
$2,027,506Martha C Sola-Visner · Boston Children'S Hospital · P01 · FY2020 · HL
Immunologic and Neurodevelopmental Consequences of Neonatal Anemia and Thrombocytopenia and their Treatments
$2,027,452Martha C Sola-Visner · Boston Children'S Hospital · P01 · FY2021 · HL
Immunologic and Neurodevelopmental Consequences of Neonatal Anemia and Thrombocytopenia and their Treatments
$2,027,405Martha C Sola-Visner · Boston Children'S Hospital · P01 · FY2022 · HL
Genes, environmental stressors, and the biobehavioral pathways to CVD
$2,027,385Redford B Williams · Duke University · P01 · FY2020 · HL
REGULATORY MANAGEMENT CENTER
$2,027,319Charity-Anne Schuller · Ppd Development Lp · N01 · FY2016 · AI
Phase III RCT of the Effectiveness of Silver Diamine Fluoride in Arresting Cavitated Caries Lesions
$2,027,212Margherita R Fontana · University Of Michigan At Ann Arbor · U01 · FY2017 · DE
Molecularly Targeted Radiosensitization of Locally Advanced Cancers
$2,027,150Theodore S Lawrence · University Of Michigan At Ann Arbor · P50 · FY2025 · CA